Cost Effectiveness of Letermovir as Cytomegalovirus Prophylaxis in in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions